Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina

    NEXT STORY
    Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
    PREV STORY
    Hemispherx Secures Corrections from Two Stock News Organizations Related to Their Inaccurate Reporting of an Equity Distribution Agreement Disclosed in a Recent SEC Filing
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Parkview Health First to Activate New SMART® and FHIR® Technology Standards Through Healthwise

    New FHIR Technology to bring innovative patient education and Engagement capabilities through modern, interoperable ...

    author_avatar
    NASDAQ Market News

    Calithera Biosciences to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology Roundtable

    SOUTH SAN FRANCISCO, Calif., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

    author_avatar
    NASDAQ Market News

    Genmab 2018 Annual Report

    author_avatar
    NASDAQ Market News